OTCMKTS:SBMFF Sino Biopharmaceutical (SBMFF) Stock Price, News & Analysis $0.70 0.00 (0.00%) As of 10/5/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and TrendsSEC FilingsShort Interest About Sino Biopharmaceutical Stock (OTCMKTS:SBMFF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sino Biopharmaceutical alerts:Sign Up Key Stats Today's Range$0.70▼$0.7050-Day Range$0.61▼$0.7552-Week Range$0.59▼$1.07VolumeN/AAverage Volume298 shsMarket Capitalization$13.04 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sino Biopharmaceutical Limited is a China-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of medicines. The company offers prescription drugs and other pharmaceutical products across areas including oncology, liver disease, respiratory conditions, digestive disorders, cardiovascular disease and orthopedics. Its business includes generic medicines, innovative therapies, biologic products and traditional Chinese medicine. Key operating subsidiaries and research units include Chia Tai Tianqing Pharmaceutical Group, which has been associated with the development and commercialization of oncology and hepatology treatments, as well as other companies focused on pharmaceutical research, manufacturing and distribution. Established in 2000, Sino Biopharmaceutical primarily serves the Chinese pharmaceutical market and has pursued international development and commercialization opportunities for selected products. The company is led by Chairman Xie Bing and Chief Executive Officer Chen Sean.AI Generated. May Contain Errors. Read More Receive SBMFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SBMFF Stock News HeadlinesGlobal Market: Hong Kong stocks rise as pharma, tech shares lead gains October 6 at 2:11 AM | economictimes.indiatimes.comSino Biopharmaceutical’s HER2-Low Breast Cancer ADC Wins China NDA AcceptanceSeptember 15, 2026 | tipranks.comThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.October 7 at 1:00 AM | Reagan Gold Group (Ad)Sino Biopharm Raises CT Tianqing Stake to 65% in RMB4.48 Billion DealSeptember 11, 2026 | tipranks.comSino Biopharm’s Kylo-11 Shows Year-Long Lp(a) Cut in Phase I TrialAugust 30, 2026 | tipranks.comSino Biopharm Wins China, U.S. Green Lights for Next-Gen Nectin-4 ADC LM-364August 28, 2026 | tipranks.comSino Biopharmaceutical (SBMFF) Receives a Buy from CitiAugust 23, 2026 | theglobeandmail.comSino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International ExpansionAugust 19, 2026 | finance.yahoo.comSee More Headlines SBMFF Stock Analysis - Frequently Asked Questions How have SBMFF shares performed this year? Sino Biopharmaceutical's stock was trading at $0.8721 on January 1st, 2026. Since then, SBMFF shares have decreased by 20.3% and is now trading at $0.6952. How do I buy shares of Sino Biopharmaceutical? Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/07/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:SBMFF Previous SymbolNASDAQ:SBMFF CIK1604982 Webwww.sbpgroup.com Phone852-2802-9886Fax852-2880-0847Employees24,379Year Founded1997Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.02 billion Price / Sales3.25 Cash Flow$0.02 per share Price / Cash Flow29.75 Book Value$0.32 per share Price / Book2.17Miscellaneous Outstanding Shares18,760,720,000Free FloatN/AMarket Cap$13.04 billion OptionableNot Optionable Beta0.75 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:SBMFF) was last updated on 10/7/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sino Biopharmaceutical Please log in to your account or sign up in order to add this asset to your watchlist. Share Sino Biopharmaceutical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
